None listed
Conditions
Brief summary
The purpose of the randomised pilot study will be to show whether gait training with the walker leads to better improvement in gait speed and independence, as compared to treadmill training with partial body weight support system. This is an introductory study which firstly is to answer whether theoretical assumptions will be confirmed during practical application, and secondly is to enable improvement in gait training and in assessment methodology.
Interventions
The program includes a series of gait training sessions with the use of an automatic walker Reha Trainer. During the rehabilitation program, participants qualified in a group with intervention (using THERA-Trainer E-GO) will participate in 15 sessions, for the next three weeks, every day from Monday to Friday. Each training session will last 45 minutes including device fit and rest periods. The effective walk time will not be less than 30 minutes per workout. All trainings will be conducted in t
The program includes a series of gait training sessions with the use of an automatic walker Reha Trainer. During the rehabilitation program, participants qualified in a group with intervention (using THERA-Trainer E-GO) will participate in 15 sessions, for the next three weeks, every day from Monday to Friday. Each training session will last 45 minutes including device fit and rest periods. The effective walk time will not be less than 30 minutes per workout. All trainings will be conducted in the Rehabilitation Clinic (obstacle-free hall). Walking training will consist of walking straight ahead (25 meters), turning back (alternating right and left) and walking in the opposite direction in a straight line. The walking speed will be adjusted to the patient's capabilities and will gradually increase in subsequent workouts. The individual gait rate achieved in the initial 10 metre walk test, will be increased by 0.05 m/s per day from 2 session. The walking exercise will be supervised by experienced physiotherapists with training in the use of the device. Each training session will be monitored and documented.
Sponsors
St. Quenn Jadwigas Regional clinical Hospital nr. 2 in Rzeszow, Poland
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
All
Age
20 Years to 70 Years
Healthy volunteers
No
Inclusion criteria
Inclusion criteria: ischemic stroke, time from stroke onset up to three months, ability to stand and walk independently with a speed up to 0.2 m/s, motor control of the affected lower limb not higher that Brunnstrom stage 3, consent for participation in the study.
Exclusion criteria
Exclusion criteria: second or another stroke, reported incident of severe heart failure and uncontrolled arterial hypertension, cognitive disorders impairing the understanding of and ability to follow instructions, visual field disturbances caused by a stroke or other visual disturbances impairing normal vision, orthopaedic disorders significantly affecting the subjects’ gait, and untreated deep vein thrombosis.
Outcome results
None listed